The Knoebel Institute for Healthy Aging hosts the Colorado Proteinopathy Symposium each December, bringing together scientists, clinicians, and trainees to share research and build collaborations around protein misfolding, aggregation, and other biological mechanisms associated with neurodegenerative disease.
Established in 2023, the symposium explores research related to Alzheimer’s disease, Parkinson’s disease, ALS, frontotemporal dementia, prion disorders, and other conditions associated with protein dysfunction. The event has quickly become KIHA’s flagship scientific convening, drawing participants from universities, research institutions, and medical centers across Colorado and beyond.
The symposium is made possible through support from the Yale Family Endowed Lectureship Fund, established by University of Denver alumnus Don Yale (’68).
2026 Colorado Proteinopathy Symposium
The fourth annual Colorado Proteinopathy Symposium will be held December 4, 2026, with William Balch, PhD, of Scripps Research Institute, serving as the keynote speaker.
The 2026 program will bring together researchers from the University of Denver, CU Boulder, CU Anschutz, Scripps Research Institute, National Jewish Health, and affiliated medical centers. The day will feature faculty presentations, trainee research talks, a student poster session, networking opportunities, and discussions highlighting new research into the biological mechanisms that contribute to neurodegenerative disease and healthy aging.
The third annual symposium welcomed 77 scientists, clinicians, and students from universities and medical centers across Colorado. Andrew Hamilton, PhD, President Emeritus of New York University, delivered the keynote address on targeting protein misfolding and aggregation using protein structural mimetics.
Featured speakers included researchers from the University of Denver, CU Boulder, CU Anschutz, Colorado State University, and National Jewish Health.
2024 Colorado Proteinopathy Symposium
James Shorter, PhD, of the Perelman School of Medicine at the University of Pennsylvania, delivered the keynote address, Countering Deleterious Phase Transitions in Neurodegenerative Disease. Researchers from institutions across Colorado presented work related to protein biology, neurodegeneration, and disease mechanisms.
2023 Inaugural Colorado Proteinopathy Symposium
The inaugural Colorado Proteinopathy Symposium brought together approximately 80 researchers from seven Colorado universities. Elizabeth Rhoades, PhD, of the University of Pennsylvania, delivered the keynote address focused on the molecular basis of Alzheimer’s disease and tau biology.
The program featured 11 faculty speakers from institutions across Colorado and 25 student poster presentations.